NCT05267080Active, not recruiting
Registry on Percutaneous Electrochemotherapy
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 11 Feb 2022
- Start date
- 25 Jan 2023
- Primary completion date
- 23 Jan 2026
- Lead sponsor
- Cardiovascular and Interventional Radiological Society of Europe
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT05267080
What you commit to
- Study type: Observational
- Planned participants: 250
- From 25 Jan 2023 to the primary completion date, 23 Jan 2026
- 15 sites in 7 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy
Who the study is looking for
- 18 years or older
- Primary or secondary liver cancer
- Referral to local ablative treatment by multidisciplinary tumour board and decision to treat with pECT by interventional radiologist in charge
- Planned treatment with pECT using the CLINIPORATOR
- Signed informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (15)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| WEGE Klinik Coordinator of this site? Confirm its status | Bonn | Germany | Unknown status |
| Stadtisches Klinikum Braunschweig Coordinator of this site? Confirm its status | Braunschweig | Germany | Unknown status |
| Universitätsklinikum Halle Coordinator of this site? Confirm its status | Halle | Germany | Unknown status |
| Helios Park-Klinikum Coordinator of this site? Confirm its status | Leipzig | Germany | Unknown status |
| University Hospital Regensburg Coordinator of this site? Confirm its status | Regensburg | Germany | Unknown status |
| Hospital Universitario Y Politecnico La Fe Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Centre Hospitalier Universitaire de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| Hôpital Européen Georges Pompidou Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Institut Gustave Roussy Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Leeds Teaching Hospitals NHS Trust Coordinator of this site? Confirm its status | Leeds | United Kingdom | Unknown status |
| University of Szeged Coordinator of this site? Confirm its status | Szeged | Hungary | Unknown status |
| Istituto Europeo di Oncologia Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| Policlinico Universitario A. Gemelli Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
| Fondazione Policlinico Universitario Campus Bio-Medico Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
| Vilnius University Hospital Santariškių Klinikos Coordinator of this site? Confirm its status | Vilnius | Lithuania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.